Home » Newsletters » BioWorld Science

BioWorld Science

July 6, 2001

View Archived Issues

Wyeth-Ayerst and Taxolog to develop novel taxanes

Licensing opportunity from NIH: novel vacuolar-type H+-ATPase inhibitors

Role for donepezil in the prophylaxis of migraine

Naratriptan superior to naproxen in prevention of menstrual migraine

New isoniazid derivative is a promising agent for TB

Susceptibility testing indicates no crossresistance for GAR-936 with other tetracyclines

Improved stability and in vivo activity achieved in novel human GLP-1 analogues

Amgen awaits FDA decision on ARANESP

CLX-090700: a synthetic analogue of a natural product with oral antidiabetic properties

New study data support lamotrigine as treatment for bipolar disorder

Pharmacological profile of AS-8112 suggests potential in emesis

Aphios and ITC/Immune Technology to develop natural therapeutic for hepatitis C

Corixa updates status of Melacine and Bexxar development programs

Additional beneficial effects reported for ezetimibe in a hamster model of combined dyslipidemia

Phytoestrogens attenuate Abeta-mediated neuronal toxicity

ISTA completes enrollment in second phase III study of Vitrase

Phytopharm's P-57 successfully completes second stage of obesity study

FDA grants approval for Debiopharm's Trelstar LA for use in advanced prostate cancer

WHI-P154 claimed for sensitizing cancer cells to radiation

Several series of antineoplastic agents presented by ADIR in patents

Enzyme-inducing sulfenate and thiosulfinate esters described by U.S. university

Alkoxyiminoalkanoic acid derivatives for the prevention, treatment of diabetes

Beta3-adrenoceptor agonists from Fujisawa particularly useful for urinary incontinence, pollakiuria

Steroid sulfatase inhibitors in development by Novartis for cancer, etc.

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...